Company News, Regulations

Warning Letter for OTC Acne & Sunscreen Manufacturer

FDA finds violations at Goshen, NY-based facility.

The US Food and Drug Administration has issued a warning letter to The Skin Atelier, Inc., d.b.a. Skinprint, Goshen, NY, following an inspection conducted from March 28 to April 4, 2019. The agency said it found significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals, including acne treatments and sunscreens including: Spot-On with 5% Micro-Benz Benzoyl Peroixde  Spot Treatment, Reflect SPF 50 Broad Spectrum Sunscreen and Blemish Control Clea...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters